Get the Stockscreener App
361.37
1.68%
-6.17
Pre-market:
360.65
-0.72
-0.20%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $361.37, with a volume of 1.78M.
It is down -1.68% in the last 24 hours and up +2.06% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$367.54
Open:
$366.44
24h Volume:
1.78M
Relative Volume:
1.09
Market Cap:
$138.20B
Revenue:
$24.38B
Net Income/Loss:
$2.94B
P/E Ratio:
47.45
EPS:
7.6159
Net Cash Flow:
$4.07B
1W Performance:
+3.61%
1M Performance:
+2.06%
6M Performance:
-7.21%
1Y Performance:
-1.17%
1-Day Range:
$358.17
$367.19
1-Week Range:
$349.00
$370.88
52-Week Range:
$329.16
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
361.37 | 140.56B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
ABT
Abbott Laboratories
|
124.64 | 218.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.72 | 144.75B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.95 | 125.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.01 | 49.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and 10x Genomics (TXG) - The Globe and Mail
Sumitomo Mitsui Trust Group Inc. Raises Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock: steady grind higher as Wall Street quietly raises the bar - AD HOC NEWS
New York State Teachers Retirement System Cuts Stock Holdings in Stryker Corporation $SYK - MarketBeat
The Truth About Stryker Corp.: Is This Quiet Med-Tech Giant a Hidden Stock Cheat Code? - AD HOC NEWS
Pharmaceutical Waste Management Market is expected to generate a revenue of USD 2631.59 Million by 2032, Globally, at 5.91% CAGR: Verified Market Research® - GlobeNewswire Inc.
Stryker Corporation $SYK Shares Sold by Parnassus Investments LLC - MarketBeat
Stryker Corporation $SYK Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Stryker (SYK) Group President Dylan Crotty discloses stock and option stakes - Stock Titan
Bernstein Raises Price Target for Stryker (SYK) to $465 | SYK St - GuruFocus
Bernstein Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $465 - 富途牛牛
Why Stryker Corporation stock stays undervaluedJuly 2025 Short Interest & Smart Allocation Stock Reports - ulpravda.ru
Will Stryker Corporation (SYK) stock see valuation expansion2025 Risk Factors & High Conviction Buy Zone Picks - ulpravda.ru
Can Stryker Corporation (SYK) stock stage a strong rebound this quarterCPI Data & Fast Entry Momentum Trade Alerts - ulpravda.ru
Will Stryker Corporation stock attract ESG investorsMarket Performance Report & Low Risk Entry Point Guides - ulpravda.ru
Noesis Capital Mangement Corp Purchases 3,381 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation (NYSE:SYK) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Raymond James Upgrade and Organic Growth Story Might Change The Case For Investing In Stryker (SYK) - Yahoo Finance
MassMutual Private Wealth & Trust FSB Increases Stock Position in Stryker Corporation $SYK - MarketBeat
DSM Capital Partners LLC Buys 14,225 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker (SYK) Stock Trades Up, Here Is Why - Finviz
Why Stryker Stock Popped Today - Finviz
Raymond James backs quality tilt in MedTech for 2026, upgrades Stryker - Investing.com
VB Spine completes acquisition of Stryker’s France manufacturing facility By Investing.com - Investing.com Canada
VB Spine completes acquisition of Stryker’s France manufacturing facility - Investing.com
Raymond James Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $418 - 富途牛牛
VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker – Company Announcement - Financial Times
What makes Stryker Corp. (SYK) a high-quality, defensive compounder? - MSN
Stryker Corporation $SYK Shares Sold by Greenleaf Trust - MarketBeat
ACT ENERGY TECHNOLOGIES COMPLETES ACQUISITION OF STRYKER DIRECTIONAL, EXPANDING PRESENCE IN THE SOUTHERN UNITED STATES - Yahoo Finance
Stryker's (NYSE:SYK) investors will be pleased with their notable 54% return over the last five years - simplywall.st
Stryker to Release Fourth Quarter and Full Year 2025 Financial Results on January 29, 2026 - Quiver Quantitative
Stryker to announce financial results for its fourth quarter and full year 2025 - Chartmill
Capital Advisors Inc. OK Grows Stock Holdings in Stryker Corporation $SYK - MarketBeat
Medical Sales Rep Salary Stryker Resentative Actual 2023 Projected 2024- - shababeek.org
Stryker Corp. stock: quiet chart, firm pulse – is this medtech leader still a buy after its latest run? - AD HOC NEWS
Stryker Corporation $SYK Shares Sold by Banque Pictet & Cie SA - MarketBeat
Stryker Corp. stock: steady climb, cautious optimism as Wall Street eyes medtech resilience - AD HOC NEWS
List of 54 Acquisitions by Stryker (Jan 2026) - Tracxn
Ascent Group LLC Increases Stake in Stryker Corporation $SYK - MarketBeat
P/E Ratio Insights for Stryker - Benzinga
Diversified Trust Co Increases Stock Holdings in Stryker Corporation $SYK - MarketBeat
Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus - ts2.tech
Ex-Dividend Reminder: National Healthcare, Stryker and Annaly Capital Management - Nasdaq
Norris Perne & French LLP MI Has $16.69 Million Stock Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Position Decreased by Ethic Inc. - MarketBeat
Boston Trust Walden Corp Reduces Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation (SYK) Stock Analysis: Evaluating a 20.86% Upside in the Medical Devices Sector - DirectorsTalk Interviews
Valley National Advisers Inc. Raises Stock Holdings in Stryker Corporation $SYK - MarketBeat
NovaPoint Capital LLC Invests $1.06 Million in Stryker Corporation $SYK - MarketBeat
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):